Quintiles takes commercial operations to Russia

US-based biopharmaceutical services company Quintiles is expanding its remit in Russia by launching its first commercial project in the market. The project involves a 40-strong sales team and comes after Quintiles set up a local legal entity to deliver commercial operations in the country and appointed Sergey Smirnov as head of business development & operations,

Continue Reading

Quintiles plans more Prime Sites in UK

Quintiles is considering setting up at least two more Prime Sites in the UK to make the most of what it regards as a still fertile environment for clinical trials. The US-based biopharmaceutical services company established the first of its international network of Prime Sites at Queen Mary, University of London in 2007. The company recently gave a further vote of confidence to the UK as a key location for clinical research by investing in a clinical research facility – part of the new William Harvey Heart Centre – at the same site.

Continue Reading